A compound normally associated with red blood cells may also play a game-changing antioxidant role in the brain, a study has ...

The influencer, 36, has partnered with adaptive clothing brand Silverts to launch a chic collection for young disabled people ...

Attaching a molecule dubbed KDS12025 to hemoglobin improved the protein's ability to neutralize abberant reactive oxygen species in the brain ...

MTPA's oral therapy Radicava (edaravone) has shown decreased functional decline and improved survival in long-term ALS trials ...

Australia’s Neurizon Therapeutics, a biotech advancing innovative treatments for neurodegenerative diseases, has reported ...

Due to a lack of resources and personnel, the FDA has delayed until October its decision on lifting a clinical hold on ALS ...

Clene Inc. plans to submit a New Drug Application (“NDA”) for lead candidate CNM-Au8® in ALS by year-end 2025. <li /> FDA meet ...

Ketamine product KETARx, produced by PharmaTher, has been approved by the FDA for use in surgical pain management.

A Jacksonville woman's experience caring for her husband with ALS has formed a foundation to help other families fighting ...

Yet another biotech is facing a delay from the FDA as the agency reels from intense staffing cuts. | Yet another biotech is ...

Neurizon Therapeutics has reported positive topline results from an open-label extension study of its lead candidate NUZ-001 ...

Jodi O’Donnell-Ames founded Hope Loves Company to provide support, resources, and community to children affected by ALS.